Raymond James Financial Services Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,694
| Closed | -$221K | – | 2775 |
|
|
2019
Q2 | $221K | Sell |
2,694
-265
| -9% | -$21.7K | ﹤0.01% | 2467 |
|
|
2019
Q1 | $209K | Buy |
+2,959
| New | +$209K | ﹤0.01% | 2476 |
|
|
2018
Q3 | – | Sell |
-3,913
| Closed | -$261K | – | 2779 |
|
|
2018
Q2 | $261K | Buy |
+3,913
| New | +$261K | ﹤0.01% | 2325 |
|
|
2017
Q4 | – | Sell |
-10,023
| Closed | -$526K | – | 2503 |
|
|
2017
Q3 | $526K | Buy |
10,023
+530
| +6% | +$27.8K | ﹤0.01% | 1678 |
|
|
2017
Q2 | $444K | Buy |
9,493
+3,837
| +68% | +$179K | ﹤0.01% | 1748 |
|
|
2017
Q1 | $280K | Buy |
+5,656
| New | +$280K | ﹤0.01% | 1939 |
|
|
2016
Q4 | – | Sell |
-6,131
| Closed | -$407K | – | 2313 |
|
|
2016
Q3 | $407K | Sell |
6,131
-15
| -0.2% | -$996 | ﹤0.01% | 1605 |
|
|
2016
Q2 | $343K | Buy |
+6,146
| New | +$343K | ﹤0.01% | 1633 |
|